Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Melissa L. Brooks"'
Autor:
Rahul Palchaudhuri, Junia Dushime, Jason Neale, Ganapathy N. Sarma, Bradley R. Pearse, Melissa L. Brooks, Charlotte Mcdonagh, Jennifer L. Proctor, Anthony E. Boitano, Tahirih L. Lamothe, Ryan Knihtila, Nidhi Jain, Rajiv Panwar, Qing Li, Sean McDonough, John C. Davis, Michael P. Cooke, Lena Kien, Kellie Latimer
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S35-S36
Current approaches to conditioning prior to transplant and gene therapy employ non-specific genotoxic agents that are associated with severe acute and long-term toxicities. Consequently, many transplant eligible patients either refuse transplant or r
Autor:
Tahirih L. Lamothe, Sean McDonough, Prashant raj Bhattarai, Oliver Mikse, Michael P. Cooke, Anthony E. Boitano, Rahul Palchaudhuri, Melissa L. Brooks, Ganapathy N. Sarma, Jennifer L. Proctor, Charlotte Mcdonagh, Geoffrey O. Gillard, Leanne Lanieri, Nidhi Jain, Lena Kien, Anjali Bhat
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S96
For patients with refractory or high-risk hematologic malignancies, like acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and acute lymphoblastic leukemia (ALL), allogeneic hematopoietic stem cell transplant (Allo-HSCT) is a potentially
Autor:
Rahul Palchaudhuri, Ganapathy N. Sarma, Melissa L. Brooks, Bradley R. Pearse, Bruce R. Blazar, Geoff O Gillard, Sharon L. Hyzy, Nicholas M. Clark, Hans-Peter Kiem, Anthony E. Boitano, John E. Wagner, Katelyn J. Hammond, Tahirih L. Lamothe, Asim Saha, Charlotte Mcdonagh, Anjali Bhat, Michael P. Cooke, Jennifer L. Proctor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S160
Introduction Allogeneic hematopoietic stem cell transplant (Allo-HSCT) is a potentially curative treatment for malignant and non-malignant blood disorders. However, current conditioning regimens limit its use due to regimen-related mortality and morb
Autor:
Anthony E. Boitano, Kellie Latimer, Rahul Palchaudhuri, Sean McDonough, Nathaniel S. Linde, Ganapathy N. Sarma, Lena Kien, Robert E. Donahue, Bradley R. Pearse, Junia Dushime, John F. Tisdale, Jennifer L. Proctor, Michael P. Cooke, Allen E. Krouse, Melissa L. Brooks, Qing Li, Aylin C. Bonifacino, Rajiv Panwar, Naoya Uchida, Pranoti Sawant, Sharon L. Hyzy, Charlotte Mcdonagh
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S6
Autologous hematopoietic stem cell transplantation (Auto-HSCT) with gene-modification represents a potential cure for multiple genetic diseases, but its broad curative potential, is limited because of morbidity/mortality from cytotoxic chemotherapy-b
Autor:
Hans J. Hertzler, Paul J. Orchard, Anthony E. Boitano, Michael P. Cooke, Kevin A. Goncalves, Melissa L. Brooks, Sharon L. Hyzy
Publikováno v:
Molecular Genetics and Metabolism. 129:S123
Autor:
Nathaniel S. Linde, Kellie Latimer, Lena Kien, John F. Tisdale, Aylin C. Bonifacino, Qing Li, Rajiv Panwar, Naoya Uchida, Robert E. Donahue, Anthony E. Boitano, Melissa L. Brooks, Sharon L. Hyzy, Rahul Palchaudhuri, Michael P. Cooke, Sean McDonough, Ganapathy N. Sarma, Bradley R. Pearse, Junia Dushime, Charlotte Mcdonagh, Allen E. Krouse, Pranoti Sawant, Jennifer L. Proctor
Publikováno v:
Blood. 134:610-610
Autologous hematopoietic stem cell transplantation (Auto-HSCT) with gene-modification techniques represents a potential cure for multiple genetic blood diseases. Despite its broad curative potential, auto-gene modified HSCT is currently limited due t
Autor:
Kevin A. Goncalves, Melissa L. Brooks, Michael P. Cooke, Sharon L. Hyzy, Hans J. Hertzler, Anthony E. Boitano
Publikováno v:
Blood. 134:4424-4424
Background . Allogeneic hematopoietic stem cell transplant (HSCT) is a promising approach to halt disease progression and prevent or ameliorate neurological symptoms arising from select inherited metabolic disorders (IMDs). Donor-derived cells, inclu
Autor:
Anjali Bhat, Michael P. Cooke, Oliver Mikse, Prashant raj Bhattarai, Charlotte F. Mcdonough, Geoff O Gillard, Tahirih L. Lamothe, Sharon L. Hyzy, Rahul Palchaudhuri, Ganapathy N. Sarma, Bradley R. Pearse, Jennifer L. Proctor, Anthony E. Boitano, Sean McDonough, Melissa L. Brooks, Pranoti Sawant
Publikováno v:
Blood. 134:3208-3208
Resetting the immune system through autologous hematopoietic stem cell transplant (autoHSCT) is a highly effective treatment in selected patients with autoimmune diseases. AutoHSCT can induce long-term remission (up to 15 years) with 70-80% progressi
Autor:
Andrew D Gabros, Olga Burenkova, Charlotte Mcdonagh, Brad R. Pearse, Anthony E. Boitano, Melissa L. Brooks, Rahul Palchaudhuri, Hillary L. Adams, Ganapathy N. Sarma, Michael P. Cooke, Sharon Aslanian, Jennifer L. Proctor, Geoff O Gillard, Sharon L. Hyzy, Tahirih L. Lamothe
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S188-S189
Bone Marrow Transplant (BMT) is a potentially curative treatment for malignant and non-malignant blood disorders. Current regimens for patient preparation, or conditioning, prior to BMT limit the use of this curative procedure due to regimen-related
Autor:
Sharon L. Hyzy, Michael P. Cooke, Kevin A. Goncalves, Melissa L. Brooks, Anthony E. Boitano, Shuping Li
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S92-S93
Allogeneic bone marrow transplant (BMT) can prevent or ameliorate neurological symptoms arising from certain inherited metabolic disorders (IMDs). Donor-derived microglial cells limit progression of neurological disease following transplant. Cord blo